Literature DB >> 17199870

Function of cardiac M3 receptors.

H Wang1, Y Lu, Z Wang.   

Abstract

1. Since the initial identification of the M3 subtype of muscarinic acetylcholine receptors (M3-mAChR) in the heart, there have been increasing interest and advances in studies on the pathophysiological roles of M3-mAChR in the heart. Recent studies from several laboratories have provided compelling and solid evidence in support of the important roles of M3-mAChR in regulation and maintenance of cardiac function and in generation and progression of heart disease as well. 2. The functions of the cardiac M3-mAChR revealed thus far include (i) M3-mAChR regulation of heart rate and cardiac repolarization, (ii) modulation of inotropic effects, (iii) cytoprotection against ischaemic injuries of myocardium, (iv) regulation of cell-to-cell communication, and (v) participation in generation and maintenance of atrial fibrillation. 3. Signal transduction mechanisms underlying these pathophysiological functions have also been studied, which have allowed us to get insight into the following mechanistic aspects. (i) M3-mAChR activates a delayed rectifying K+ current I(KM3) to participate in cardiac repolarization, negative chronotropic actions, and anti-dysrhythmic (suppresses ischaemic dysrhythmias) as well as pro-dysrhythmic (facilitates atrial fibrillation) actions. (ii) M3-mAChR interacts with gap-junctional channel connexin 43 to maintain cell-cell communication and excitation propagation. (iii) M3-mAChR regulates intracellular phosphoinositide hydrolysis to improve cardiac contraction and haemodynamic function. (iv) M3-mAChR activate anti-apoptotic signalling molecules, enhances endogenous antioxidant capacity, and diminishes intracellular Ca2+ overload, all of which contribute to protecting the heart against ischaemic injuries. 4. This article provides an overview of the potential roles of the M3-mAChR in parasympathetic control of heart function under normal physiological conditions and in the setting of a variety of pathological processes including heart failure, myocardial ischaemia and dysrhythmias.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17199870     DOI: 10.1111/j.1474-8673.2006.00381.x

Source DB:  PubMed          Journal:  Auton Autacoid Pharmacol        ISSN: 1474-8665


  28 in total

1.  Functional M3 cholinoreceptors are present in pacemaker and working myocardium of murine heart.

Authors:  Denis V Abramochkin; Svetlana V Tapilina; Galina S Sukhova; Eugen E Nikolsky; Leniz F Nurullin
Journal:  Pflugers Arch       Date:  2012-02-15       Impact factor: 3.657

2.  Voltage sensitivity of M2 muscarinic receptors underlies the delayed rectifier-like activation of ACh-gated K(+) current by choline in feline atrial myocytes.

Authors:  Ricardo A Navarro-Polanco; Iván A Aréchiga-Figueroa; Pedro D Salazar-Fajardo; Dora E Benavides-Haro; Julio C Rodríguez-Elías; Frank B Sachse; Martin Tristani-Firouzi; José A Sánchez-Chapula; Eloy G Moreno-Galindo
Journal:  J Physiol       Date:  2013-05-07       Impact factor: 5.182

3.  M3 cholinoreceptors alter electrical activity of rat left atrium via suppression of L-type Ca2+ current without affecting K+ conductance.

Authors:  Tatiana S Filatova; Nikolay Naumenko; Pavel A Galenko-Yaroshevsky; Denis V Abramochkin
Journal:  J Physiol Biochem       Date:  2016-11-17       Impact factor: 4.158

4.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

5.  Muscarinic-activated potassium current mediates the negative chronotropic effect of pilocarpine on the rabbit sinoatrial node.

Authors:  Martín Rodríguez-Martínez; Iván A Aréchiga-Figueroa; Eloy G Moreno-Galindo; Ricardo A Navarro-Polanco; José A Sánchez-Chapula
Journal:  Pflugers Arch       Date:  2011-04-13       Impact factor: 3.657

6.  Electrophysiological differences in cholinergic signaling between the hearts of summer and winter frogs (Rana temporaria).

Authors:  Denis Abramochkin; Vladislav Kuzmin
Journal:  J Comp Physiol B       Date:  2018-02-10       Impact factor: 2.200

7.  Effects of acetylcholinesterase inhibitor paraoxon denote the possibility of non-quantal acetylcholine release in myocardium of different vertebrates.

Authors:  Denis V Abramochkin; Anastasia A Borodinova; Leonid V Rosenshtraukh
Journal:  J Comp Physiol B       Date:  2011-07-15       Impact factor: 2.200

8.  Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents.

Authors:  Hideaki Kanazawa; Masaki Ieda; Kensuke Kimura; Takahide Arai; Haruko Kawaguchi-Manabe; Tomohiro Matsuhashi; Jin Endo; Motoaki Sano; Takashi Kawakami; Tokuhiro Kimura; Toshiaki Monkawa; Matsuhiko Hayashi; Akio Iwanami; Hideyuki Okano; Yasunori Okada; Hatsue Ishibashi-Ueda; Satoshi Ogawa; Keiichi Fukuda
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

9.  The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles.

Authors:  Jaromir Myslivecek; Martin Klein; Martina Novakova; Jan Ricny
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-04-29       Impact factor: 3.000

10.  Reciprocal regulation between M3 muscarinic acetylcholine receptor and protein kinase C-epsilon in ventricular myocytes during myocardial ischemia in rats.

Authors:  Peng-zhou Hang; Jing Zhao; Yu-ping Wang; Li-hua Sun; Yong Zhang; Li-li Yang; Na Zhao; Zhi-dan Sun; Yu-ying Mao; Zhi-min Du
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.